We have some great news to share:
Tergus (www.terguspharma.com), the industry leader in topical pharmaceutical development, skin biology & IVRT testing and Phase I – III cGMP clinical supply manufacturing, has hired Ms. Kelly Thomas to head the company’s Quality Assurance (QA) and Compliance departments. Ms. Thomas has more than 18 years of experience in developing, implementing and managing QA and cGMP operations.
“We are very pleased to have Kelly join Tergus,” said Vijendra Nalamothu, PhD, CEO and co-founder of Tergus. “Her stellar record as an uncompromising QA leader will fit well with our commitment to excellence and quality.”
Ms. Thomas holds a Bachelor of Science in Biology from East Carolina University and an MBA from Meredith College. She also maintains several professional certifications from the American Society for Quality (ASQ). Her professional career has been spent developing and implementing quality systems to ensure that compliance strategies are consistent with customer needs and expectations; regulatory requirements and corporate goals.
The hiring of Thomas is another step in Tergus’ strong commitment to quality. The company has a fully-implemented Quality by Design (QbD) program that has resulted in strong benefits for clients not only during the development and formulation phases, but also during clinical supply manufacture, scale-up and tech transfer. Tergus has a state-of-the-art clinical supply manufacturing facility and has worked with clients to ensure smooth scale up.
Tergus offers complete topical pharmaceutical development, formulation, analytical R&D, In Vitro Release Testing (IVRT), skin biology and cGMP clinical supplies manufacturing. The company has capability to produce clinical supplies up to 150kg using their state of the art manufacturing equipment. The company’s motto is “Think Topical, Think Tergus.”